ANDA 73529, held by Watson Labs. Doxapram Hydrochloride.
As of Nov 16, 2026, ANDA 73529 (Doxapram Hydrochloride), held by Watson Labs, was first approved by FDA on Jan 30, 1992, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 30, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Doxapram Hydrochloride20MG/ML ยท injectable;injection | Doxapram Hydrochloride | Discontinued |
| Feb 19, 1999 | Supplement 4Manufacturing | Approved | None posted |
| Feb 2, 1999 | Supplement 2Manufacturing | Approved | None posted |
| Dec 4, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Jan 30, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters